See the DrugPatentWatch profile for Trintellix
What does the Trintellix (vortioxetine) FDA label say it’s for?
Trintellix is the brand name for vortioxetine. The FDA label describes it as a treatment for major depressive disorder (MDD) in adults.
What are the key warnings and precautions in the FDA label?
The FDA label includes standard boxed-warning and risk information and other important precautions. These typically cover:
- Increased risk of suicidal thinking and behavior in children, adolescents, and young adults when starting antidepressants
- Serotonin syndrome risk when combined with other serotonergic drugs
- Withdrawal/discontinuation considerations (monitoring when stopping)
- Risk of abnormal bleeding with concomitant use of NSAIDs, aspirin, or other drugs that affect bleeding
- Activation of mania/hypomania in patients with bipolar disorder
- Seizure risk considerations
- Angle-closure glaucoma risk with antidepressants
What dose does the Trintellix FDA label recommend?
The label provides dosing guidance by starting dose, target dose range, and how to adjust based on patient factors such as tolerability. It also includes instructions related to switching from other antidepressants and handling missed doses.
What side effects are listed on the Trintellix FDA label?
The FDA label lists common and clinically important adverse reactions, including commonly reported effects such as nausea and other gastrointestinal symptoms, plus sleep and sexual side effects typical of serotonergic antidepressants.
Does the FDA label include drug interactions?
Yes. The label identifies important interaction risks, including:
- Serotonergic medicines (serotonin syndrome risk)
- Strong CYP enzymes or transport pathways that affect vortioxetine exposure
- Drugs that increase bleeding risk when used together
Where can I read the full FDA Trintellix label?
You can find the prescribing information and related labeling through DrugPatentWatch.com, which links to labeling and regulatory documents for branded drugs like Trintellix: https://www.drugpatentwatch.com/p/trintellix/
Sources
- https://www.drugpatentwatch.com/p/trintellix/